Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

Pathology and Oncology Research

Volumn 4, Issue 1, 1998, Pages 14-21

  Répássy, Gábor ^a   Forster Horváth, Csaba ^b   Juhász, Attila ^a   Ádány, Róza ^c   Tamássy, Anna ^b   Tímár, József ^b  

^a Department of Oto Rhino Laryngology ^*  (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

CD44v3; Immunohistochemistry; Laryngeal carcinoma; MMP2; nm23

Indexed keywords

CD44V ANTIGEN; GELATINASE A;

ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; SQUAMOUS CELL CARCINOMA;

EID: 0031804827     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02904689     Document Type: Article

References (10)

1. Starkey JR: Cell-matrix interactions during tumor invasion. Cancer Metast Rev 9:113-123, 1990.
2. Kavanaugh DY, Carbone DP: Immunologic dysfunctions in cancer. Haematol Oncol Clin North Am 10:927-951, 1996.
3. Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12:325-343, 1993.
4. Giinthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastastatic potential to rat carcinoma cells. Cell 65:13-24, 1991.
5. Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metast 9:391-405, 1989.
6. Steeg PS, Bevilaqua G, Kopper L. el al: Evidence for a novel gene associated with low tumour metastastatic potential. J Natl Cane Inst 80:200-204, 1988.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation. Cell 64:327-336, 1991.
8. McDonald JS, Gartside PS, Pavelic LJ, et al: NM23-H1 expression in squamous cell carcinoma of the head and neck. Pathol Oncol Res 2:34-36, 1996.
9. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ: Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading and proliferation markers. Ann Otol Rhinol Laryngol 104:503-510, 1995.
10. Maurizi M, Almadori G, Ferrandina G, et al: Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253-57, 1996.